Oral News and Research

RSS

Kallikrein gene variants modulate OSCC development

Polymorphisms in the kallikrein7 and kallikrein10 genes are associated with the development and progression of oral squamous cell carcinoma, a study in Taiwanese men indicates.

1 Mar 2013

Registration open for Society of Interventional Radiology's Annual Scientific Meeting

Online meeting registration is open for the Society of Interventional Radiology's Annual Scientific Meeting April 13 at the Ernest N. Morial Convention Center in New Orleans.

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI)) to the Japanese Ministry of Health, Labor and Welfare.

27 Feb 2013

IFR, PBL to further develop Dynamic Gastric Model

The Dynamic Gastric Model, developed from years of research at the Institute of Food Research, has taken significant steps towards improving its commercial use by food and drug companies worldwide.

26 Feb 2013

Prime Time can lead to long-term reductions in sexual risk among vulnerable youth

More consistent use of condoms, oral contraception or both was reported by a group of teenage girls who took part in a youth development intervention aimed at reducing pregnancy risk in high-risk adolescents, according to a report of a randomized controlled trial published Online First by JAMA Pediatrics, a JAMA Network publication.

26 Feb 2013

4SC Discovery enters exclusive research and license agreement with LEO Pharma

LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into an exclusive research and license agreement with the German biotech company 4SC Discovery GmbH with the primary aim of jointly researching, developing and commercialising an oral treatment for inflammatory skin diseases such as psoriasis.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that the first patient has been dosed in a Phase 1b clinical study of AVX-470, an oral anti-TNF antibody, for the treatment of ulcerative colitis.

25 Feb 2013

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

Merck, known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company's investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

25 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013

Oral health in elderly Chileans improving, but disparities remain

Oral health makes a significant contribution to the general wellbeing of older people, a survey of Chilean over-60s has found.

25 Feb 2013

Mechanisms of HPV-associated tumor spread under scrutiny

In patients with human papillomavirus-associated tonsillar carcinoma, second tumors in the contralateral tonsil are typically caused by the same viral variant, a case series indicates.

25 Feb 2013

PANO-VAC launches new products for general surgeries and dentistry

PANO-VAC Surgical Instruments, Inc. is pleased to announce the launch of our new products that are useful in general surgeries and dentistry, RetractorPlus and AspiratorPlus.

23 Feb 2013

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).

23 Feb 2013

Major doctor group coalition expands list of tests, treatments that should be done only rarely

The American Board of Internal Medicine, as part of its "Choosing Wisely" campaign, expanded the number of medical societies recommending caution before certain tests and procedures are ordered.

22 Feb 2013

Oral polio vaccine cold chain disruption in Pakistan could compromise immunization effectiveness, health officials warn

Health officials in Pakistan have formally complained to the WHO concerning the quality of oral polio vaccine (OPV) doses distributed by the U.N. body," SciDev.Net reports, noting 58 children became infected with polio in 2012 despite having received the vaccine.

22 Feb 2013

Working toward polio eradication in 2018

"Since the eradication of smallpox in the late 1970s, no other diseases have followed suit; the goal that has come closest so far is eradication of polio," a Lancet Infectious Diseases editorial states, noting that in 2012 only about 250 people were infected with polio worldwide.

20 Feb 2013

Mouthrinse use associated with reduced plaque and gingivitis

New research published in the January/February 2013 issue of General Dentistry, the peer-reviewed clinical journal of the Academy of General Dentistry (AGD), indicates that the use of a germ-killing mouthrinse in addition to regular toothbrushing can significantly reduce plaque and gingivitis, more so than brushing alone.

20 Feb 2013

Oral News and Research

Kallikrein gene variants modulate OSCC development

Registration open for Society of Interventional Radiology's Annual Scientific Meeting

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Ampio Pharmaceuticals starts Optina clinical trial

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

IFR, PBL to further develop Dynamic Gastric Model

Prime Time can lead to long-term reductions in sexual risk among vulnerable youth

4SC Discovery enters exclusive research and license agreement with LEO Pharma

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

WOEST supports clopidogrel only in PCI patients on anticoagulation

Oral health in elderly Chileans improving, but disparities remain

Mechanisms of HPV-associated tumor spread under scrutiny

PANO-VAC launches new products for general surgeries and dentistry

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Major doctor group coalition expands list of tests, treatments that should be done only rarely

Oral polio vaccine cold chain disruption in Pakistan could compromise immunization effectiveness, health officials warn

Working toward polio eradication in 2018

Mouthrinse use associated with reduced plaque and gingivitis

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News